Cargando…

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats

BACKGROUND: A growing body of evidence suggests that neuroinflammation, which is characterized by infiltration of immune cells, activation of mast cells and glial cells, and production of inflammatory mediators in the peripheral and central nervous systems, plays an important role in the induction a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seol, Tai-Kyung, Lee, Wonho, Park, Sunah, Kim, Kyu Nam, Kim, Tae Yeon, Oh, You Na, Jun, Jong Hun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Anesthesiologists 2017
Materias:	Experimental Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645590/ https://www.ncbi.nlm.nih.gov/pubmed/29046777 http://dx.doi.org/10.4097/kjae.2017.70.5.561

Ejemplares similares

Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain
por: Cocito, Dario, et al.
Publicado: (2014)

Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients
por: Schifilliti, Chiara, et al.
Publicado: (2014)

Comment on “Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain”
por: Kriek, R.
Publicado: (2014)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
por: D’Amico, Ramona, et al.
Publicado: (2020)

Sec-O-glucosylhamaudol mitigates inflammatory processes and autophagy via p38/JNK MAPK signaling in a rat neuropathic pain model
por: Oh, Seon Hee, et al.
Publicado: (2021)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

Anti-nociceptive effects of dual neuropeptide antagonist therapy in mouse model of neuropathic and inflammatory pain
por: Kim, Min Su, et al.
Publicado: (2022)

Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series
por: Hesselink, Jan M Keppel, et al.
Publicado: (2012)

The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice
por: Cristiano, Claudia, et al.
Publicado: (2022)

Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence
por: Scuteri, Damiana, et al.
Publicado: (2022)

The changes of mitochondrial cytochrome c and GABAergic neuron in neuropathic pain model
por: Kim, Won Sung, et al.
Publicado: (2012)

Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice
por: Guida, F., et al.
Publicado: (2015)

A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain
por: Pickering, Emily, et al.
Publicado: (2022)

Novel Approach to the Treatment of Neuropathic Pain Using a Combination with Palmitoylethanolamide and Equisetum arvense L. in an In Vitro Study
por: Ruga, Sara, et al.
Publicado: (2023)

Role of Resolvins in Inflammatory and Neuropathic Pain
por: Park, Jaeik, et al.
Publicado: (2023)

Gender differences in paclitaxel-induced neuropathic pain behavior and analgesic response in rats
por: Hwang, Boo-Young, et al.
Publicado: (2012)

Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain
por: Boccella, Serena, et al.
Publicado: (2019)

Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
por: Gabrielsson, Linda, et al.
Publicado: (2016)

Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain
por: Ardizzone, Alessio, et al.
Publicado: (2021)

Anti-inflammatory activity of palmitoylethanolamide ameliorates osteoarthritis induced by monosodium iodoacetate in Sprague–Dawley rats
por: Jung, Jae In, et al.
Publicado: (2021)

Efficacy of a Combination of N-Palmitoylethanolamide, Beta-Caryophyllene, Carnosic Acid, and Myrrh Extract on Chronic Neuropathic Pain: A Preclinical Study
por: Fotio, Yannick, et al.
Publicado: (2019)

Intrathecal Gabapentin Increases Interleukin-10 Expression and Inhibits Pro-Inflammatory Cytokine in a Rat Model of Neuropathic Pain
por: Lee, Byung-Sang, et al.
Publicado: (2013)

A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models
por: Britti, Domenico, et al.
Publicado: (2017)

The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020)

Syringaresinol Alleviates Oxaliplatin-Induced Neuropathic Pain Symptoms by Inhibiting the Inflammatory Responses of Spinal Microglia
por: Lee, Ji Hwan, et al.
Publicado: (2022)

Mesenchymal stem cell spheroids alleviate neuropathic pain by modulating chronic inflammatory response genes
por: Lee, Nayeon, et al.
Publicado: (2022)

G protein-coupled receptor, family C, group 5 (GPRC5B) downregulation in spinal cord neurons is involved in neuropathic pain
por: Chung, Hyung-Joo, et al.
Publicado: (2014)

Analgesic Effect of Harpagophytum procumbens on Postoperative and Neuropathic Pain in Rats
por: Lim, Dong Wook, et al.
Publicado: (2014)

Palmitoylethanolamide: Prenatal Developmental Toxicity Study in Rats
por: Deshmukh, Narendra S., et al.
Publicado: (2021)

Muscovite nanoparticles mitigate neuropathic pain by modulating the inflammatory response and neuroglial activation in the spinal cord
por: Oh, Ju-Young, et al.
Publicado: (2020)

The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats
por: Siracusa, Rosalba, et al.
Publicado: (2020)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
por: Stochino Loi, Emanuela, et al.
Publicado: (2019)

Prostaglandin D(2) contributes to cisplatin-induced neuropathic pain in rats via DP2 receptor in the spinal cord
por: Li, Yaqun, et al.
Publicado: (2021)

Food-Derived Natural Compounds for Pain Relief in Neuropathic Pain
por: Lim, Eun Yeong, et al.
Publicado: (2016)

Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review
por: Passavanti, Maria Beatrice, et al.
Publicado: (2019)

Effects of the glial modulator palmitoylethanolamide on chronic pain intensity and brain function
por: Alshelh, Zeynab, et al.
Publicado: (2019)

Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?
por: della Rocca, Giorgia, et al.
Publicado: (2021)

Delay of Morphine Tolerance by Palmitoylethanolamide
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

Rediscovery of Nefopam for the Treatment of Neuropathic Pain
por: Kim, Kyung Hoon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4nejkq8okfli0tte5t8lsva748